Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case
Nurix Therapeutics gained $700 million upfront from Roche, a 50% U.S. profit share and Roche-funded global bexobrutideg development,…
NASDAQ
NRIX
1 story
$2.3B Market cap · 2026-10-08
Nurix Therapeutics gained $700 million upfront from Roche, a 50% U.S. profit share and Roche-funded global bexobrutideg development,…